Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000766802 | SCV000240852 | uncertain significance | not provided | 2021-02-08 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 18179895, 22365836, 23714751, 22872700) |
Genetic Services Laboratory, |
RCV000187270 | SCV000247067 | uncertain significance | not specified | 2014-09-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000515288 | SCV000611465 | uncertain significance | Autism, susceptibility to, 15; Cortical dysplasia-focal epilepsy syndrome | 2017-05-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000644724 | SCV000766427 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 1253 of the CNTNAP2 protein (p.Ile1253Thr). This variant is present in population databases (rs767821521, gnomAD 0.1%). This missense change has been observed in individual(s) with autism spectrum disorders and/or clinical features of Pitt-Hopkins-like syndrome (PMID: 18179895; Invitae). ClinVar contains an entry for this variant (Variation ID: 205319). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change does not substantially affect CNTNAP2 function (PMID: 22872700). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002314712 | SCV000848133 | likely benign | Inborn genetic diseases | 2022-10-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000766802 | SCV001143649 | likely benign | not provided | 2019-01-23 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000644724 | SCV001519896 | uncertain significance | Cortical dysplasia-focal epilepsy syndrome | 2019-08-23 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000187270 | SCV005185233 | likely benign | not specified | 2024-05-20 | criteria provided, single submitter | clinical testing | Variant summary: CNTNAP2 c.3758T>C (p.Ile1253Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00021 in 251416 control chromosomes, predominantly at a frequency of 0.0014 within the Latino subpopulation in the gnomAD database. c.3758T>C has been reported in the literature in individuals affected with Autism but has not segregated with disease (Bakkaloglu_2008) . These report(s) do not provide unequivocal conclusions about association of the variant with Autism, Susceptibility To, 15. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 18179895). ClinVar contains an entry for this variant (Variation ID: 205319). Based on the evidence outlined above, the variant was classified as likely benign. |
Genome |
RCV000644724 | SCV001423449 | not provided | Cortical dysplasia-focal epilepsy syndrome | no assertion provided | phenotyping only | Variant interpretted as Uncertain significance and reported on 09-25-2019 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Genome |
RCV000644724 | SCV003931175 | not provided | Cortical dysplasia-focal epilepsy syndrome | no assertion provided | phenotyping only | Variant classified as Uncertain significance and reported on 07-29-2020 by Invitae. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. |